|
|
Docu-menta >
Buscar por Autor Murillas, R
Mostrando resultados 1 a 11 de 11
| Fecha de publicación | Título | Autor(es) | | may-2019 | Clinically Relevant Correction of Recessive Dystrophic Epidermolysis Bullosa by Dual sgRNA CRISPR/Cas9-Mediated Gene Editing | Bonafont, J; Mencía, A; García, M; Torres, R; Rodríguez, S; Carretero, M; Chacón-Solano, E; Modamio-Høybjør, S; Marinas, L; León, C; Escámez, MJ; Hausser, I; del Río, M; Murillas, R; Larcher, F |
| abr-2016 | Correction of a Recurrent COL7A1 Mutation in Recessive Dystrophic Epidermolysis Bullosa Keratinocytes | Chamorro, C; Mencía, A; Almarza, D; Duarte, B; Büning, H; Sallach, J; Hausser, I; Larcher, F; Murillas, R |
| jun-2021 | Correction of recessive dystrophic epidermolysis bullosa by homology-directed repair-mediated genome editing | Bonafont, J; Mencía, A; Chacón-Solano, E; Srifa, W; Vaidyanathan, S; Romano, R; García, M; Hervás-Salcedo, R; Ugalde, L; Duarte, B; Porteus, MH; del Río, M; Larcher, F; Murillas, R |
| jun-2018 | Deletion of a Pathogenic Mutation-Containing Exon of COL7A1 Allows Clonal Gene Editing Correction of RDEB Patient Epidermal Stem Cells | Mencía, A; Chamorro, C; Bonafont, J; Duarte, B; Holguin, A; Illera, N; Llames, SG; Escámez, MJ; Hausser, I; del Río, M; Larcher, F; Murillas, R |
| jun-2020 | Efficient CRISPR-Cas9-Mediated Gene Ablation in Human Keratinocytes to Recapitulate Genodermatoses: Modeling of Netherton Syndrome | Gálvez, V; Chacón-Solano, E; Bonafont, J; Mencía, A; Wei-Li, D; Murillas, R; Llames, S; Vicente, A; del Río, M; Carretero, M; Larcher, F |
| abr-2016 | Identification of two rare and novel large deletions in ITGB4 gene causing epidermolysis bullosa with pyloric atresia | Mencía, A; García, M; García, E; Llames, S; Charlesworth, A; de Lucas, R; Vicente, A; Trujillo-Tiebas, MJ; Coto, P; Costa, M; Vera, A; López-Pestaña, A; Murillas, R; Meneguzzi, G; Jorcano, JL; Conti, CJ; Escámez-Toledano, MJ; del Río, M |
| sep-2013 | Keratinocyte cell lines derived from severe generalized recessive epidermolysis bullosa patients carrying a highly recurrent COL7A1 homozygous mutation: models to assess cell and gene therapies in vitro and in vivo | Chamorro, C; Almarza, D; Duarte, B; Llames, SG; Murillas, R; García, M; Cigudosa, JC; Espinosa-Hevia, L; Escámez, MJ; Mencía, A; Meana, A; García-Escudero, R; Moro, R; Conti, CJ; del Río, M; Larcher, F |
| abr-2022 | Non-viral delivery of CRISPR-Cas9 complexes for targeted gene editing via a polymer delivery system | O'Keeffe Ahern, J; Lara-Saez, I; Zhou, D; Murillas, R; Bonafont, J; Mencía, A; García, M; Manzanares, D; Lynch, J; Foley, R; Qian, X; Sigen, A; Larcher, F; Wang, W |
| jul-2024 | Nonviral CRISPR/Cas9 mutagenesis for streamlined generation of mouse lung cancer models | Lara-Sáez, I; Mencía, A; Recuero, E; Li, Y; García, M; Oteo, M; Gallego, MI; Enguita, AB; de Prado-Verdún, D; Sigen, A; Wang, W; García-Escudero, R; Murillas, R; Santos, M |
| sep-2022 | Preclinical model for phenotypic correction of dystrophic epidermolysis bullosa by in vivo CRISPR-Cas9 delivery using adenoviral vectors | García, M; Bonafont, J; Martínez-Palacios, J; Xu, R; Turchiano, G; Svenson, S; Thrasher, AJ; Larcher, F; del Río, M; Hernández-Alcoceba, R; Garín, MI; Mencía, A; Murillas, R |
| 6-abr-2014 | Targeted gene therapy and cell reprogramming in Fanconi anemia | Rio, P; Baños, R; Lombardo, A; Quintana-Bustamante, O; Alvarez, L; Garate, Z; Genovese, P; Almarza, E; Valeri, A; Díez, B; Navarro, S; Torres, Y; Trujillo, JP; Murillas, R; Segovia, JC; Samper, E; Surralles, J; Gregory, PD; Holmes, MC; Naldini, L; Bueren, JA |
Mostrando resultados 1 a 11 de 11
|
